Huan Zhu

Mr. Huan Zhu

Xidian University, Xi'an, China
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Huan ZhuHuan Zhu
Huan Zhu
CAChun-Yan Ao
Chun-Yan Ao
YDYijie Ding
Yijie Ding
HHHongxia Hao
Hongxia Hao
LYLiang Yu
Liang Yu
Dihydrouridine (D) is an abundant post-transcriptional modification present in transfer RNA from eukaryotes, bacteria, and archaea. D has contributed to treatments for cancerous diseases. Therefore, the precise detection of D modification sites can enable further understanding of its functional roles. Traditional experimental techniques to identify D are laborious and time-consuming. In addition, there are few computational tools for such analysis. In this study, we utilized eleven sequence-derived feature extraction methods and implemented five popular machine algorithms to identify an optimal model. During data preprocessing, data were partitioned for training and testing. Oversampling was also adopted to reduce the effect of the imbalance between positive and negative samples. The best-performing model was obtained through a combination of random forest and nucleotide chemical property modeling. The optimized model presented high sensitivity and specificity values of 0.9688 and 0.9706 in independent tests, respectively. Our proposed model surpassed published tools in independent tests. Furthermore, a series of validations across several aspects was conducted in order to demonstrate the robustness and reliability of our model.

5 December 2023
Verified
Conference Paper
Closed access
LYLiang Yu
Liang Yu
DDDa Dong
Da Dong
Huan ZhuHuan Zhu
Huan Zhu
LGLin Gao
Lin Gao
Gene expression profiles play a significant role in drug research. If the gene expression profile under the action of drugs can be obtained quickly, such as through computational methods, the analysis of the relationship between the drug and the disease will become more comprehensive. The efficiency can be improved and costs can be reduced while exploring the effect of the drug. We developed an algorithm (ppc-GAN, predict-profile-conditional Generative Adversarial Networks) for predicting gene expression profiles for drug effects, which can efficiently and accurately obtain the gene expression profiles after drug administration. Compared with traditional algorithms, ppc-GAN does not require more prior knowledge. Therefore, the final prediction result will not be affected by the preference of prior knowledge. Our ppc-GAN mainly includes two parts—an autoencoder and a generative adversarial network (GAN). We trained the autoencoder through all gene expression profile data in the LINCS database and then merged the trained autoencoder into the GAN for data compression and decompression. Besides, we chose bortezomib as the case drug. Our results show that our model is flexible and has high representative power. Furthermore, the state of the gene expression profile after using the drug can be estimated by the deep learning models.